Farmaceutica. Cresce l’export, diminuisce la Ricerca & Sviluppo

PHARMA and the purity of medicines

L’industria farmaceutica has a lot of dirty laundry. Now, to help clean up The  production plants both in the United States e all’estero, the Department of Justice of the United States promises to take a "posizione particularly dura" at the plants to ensure safety and purity of prescription drugs.
L’aumentata attenzione del Department of Justice represents a change sull’applicazione degli approcci of the past Government in which US Food & Drug Administration aveva preso l’iniziativa to start investigations on production plants pharmaceutical for violations of good manufacturing standards (GMP).
While the FDA continue to have a key role, The informants they use the False Claims Act That has opened the door to un coinvolgimento più attivo of the Department of Justice in matters of enforcement against i offenders più sporchi. The Department of Justice investigate tutte  le lawsuits filed under the False Claims Act, including those That they argue Medicare and others health programs governments that have been defrauded for paying drugs adulterated.
Translation by Riccardo Bevilacqua
Source: http://www.forbes.com/sites/erikakelton/2013/06/06/

Exit mobile version